REQUEST A DEMO
Total
USD $0.00
Search more companies

Grifols Malaysia Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Grifols Malaysia Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Grifols Malaysia Sdn. Bhd. is based in Malaysia, with the head office in Petaling Jaya. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was incorporated on September 16, 1997. In 2023, the company reported a net sales revenue drop of 5.94%. There was a total growth of 38.14% in Grifols Malaysia Sdn. Bhd.’s total assets over the same period. The net profit margin of Grifols Malaysia Sdn. Bhd. increased by 3.28% in 2023.

Headquarters
Suite 12-8, The Office Club, Level 12, Menara Mudajaya, No. 12A, Jalan Pju 7/3, Mutiara Damansara
Petaling Jaya; Selangor; Postal Code: 47810

Contact Details: Purchase the Grifols Malaysia Sdn. Bhd. report to view the information.

Basic Information
Registered Capital:
Purchase the Grifols Malaysia Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Grifols Malaysia Sdn. Bhd. report to view the information.
Incorporation Date:
September 16, 1997
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
49%
Company Performance
Financial values in the chart are available after Grifols Malaysia Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-5.94%
Total operating revenue
-5.94%
Operating profit (EBIT)
57.77%
EBITDA
50.78%
Net Profit (Loss) for the Period
55.29%
Total assets
38.14%
Total equity
25.35%
Operating Profit Margin (ROS)
4.48%
Net Profit Margin
3.28%
Return on Equity (ROE)
3.89%
Quick Ratio
-1.17%
Cash Ratio
0.41%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?